tradingkey.logo
tradingkey.logo
Search

Healthpeak Properties Inc

DOC
Add to Watchlist
19.560USD
+0.160+0.82%
Close 06/18, 16:00ETQuotes delayed by 15 min
13.59BMarket Cap
61.31P/E TTM

Earnings Forecast

Currency: USD Updated: 2026-06-18
Previous score
7.26
Change
0
The current earnings forecast score of Healthpeak Properties Inc is 7.26, ranking 76 out of 191 in the Residential & Commercial REITs industry. The average price target is 20.00, with a high of 29.00 and a low of 18.00.

Analyst Rating

Based on 19 analysts
Buy
Current Rating
20.765
Target Price
+6.16%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

92
Total
8
Median
9
Average
Company name
Ratings
Analysts
Healthpeak Properties Inc
DOC
19
Digital Realty Trust Inc
DLR
33
Equinix Inc
EQIX
33
VICI Properties Inc
VICI
25
American Tower Corp
AMT
25
Gaming and Leisure Properties Inc
GLPI
24
1
2
3
...
19

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Forecast
Actual

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

FAQs

What is Healthpeak Properties Inc's expected revenue for the next quarter?

Healthpeak Properties Inc's expected revenue is 707.08M.

What is Healthpeak Properties Inc's price target?

Analysts forecast that Healthpeak Properties Inc's price target is USD 20.00, with the highest forecast at USD 29.00 and the lowest forecast at USD 18.00.

How have Healthpeak Properties IncDOC's recent earnings per share performed?

The market expectation was USD 0.28, while Healthpeak Properties IncDOC's earnings per share (EPS) for the previous quarter was USD 0.16. EPS for the next quarter is expected at USD 0.04.

What is the analyst rating for Healthpeak Properties Inc?

Based on the ratings of Healthpeak Properties Inc's stock from 19 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
KeyAI